Learn More Our Grants Fund
and HOPE
Our Mission
Learn More Your Gift
Will Fund
Breakthroughs In
Lung Cancer Research
Learn More Join Us
And Help
Find A Cure for
Lung Cancer
Get Involved
Learn More Prelude Funded
Is Already
Making an Impact

Passion. Purpose. Progress. In that order.


From the desk of Ros Miller

We have the solution!  Join the Prelude team because our solution is fun, different, easy, not expensive and you’ll feel good joining.  Make a small donation of $10 and then pick up a set of knitting needles or a crochet hook and some yarn and purposefully, intentionally make something with love that will…

Continue Reading
Dr RObinson and Board Member celebrating his knitting

Why we give

Lung cancer doesn’t care. It doesn’t care who you are, what you do, where you live, how you live, even if you smoked. Lung cancer just doesn’t care.  I care!      We care!      You can too! The Prelude to a Cure Board at our Recent Knit-A-Lung Fundraiser. Anyone can get lung cancer….

Continue Reading

Join Our Knit-A-Lung!

If you don’t knit, we can teach you or hook you up with a teacher. Why is a cancer research charity involved in knitting? It turns out that the knitting and fiber arts community are driven by Passion, Purpose and Progress, sharing the same way we feel about finding a cure for cancer. Not long…

Continue Reading

Welcome to the New Prelude to a Cure

2020 is in the rearview mirror as the year no one was prepared for. During COVID, Prelude to a Cure (Prelude/P2AC) found itself at odds with our mission and goal with the need to be safe and socially distant from each other. Though, we were not idle. The Board of Prelude took a look at ourselves…

Continue Reading

Prelude to a Cure Shines a Light on Cancer Research

Meet Dr. Boyle Dr. Theresa Boyle is a pathologist – a self-described doctor’s doctor.  Her role is to analyze and interpret biopsied tissue samples for thoracic oncologists and surgeons to develop patient treatment plans. Her career at Moffitt Cancer Center began two and a half years ago and she divides her efforts between the Thoracic and…

Continue Reading

Mourning a Cancer Hero – Dr. Charles WIlliams

<This tribute was written by Prelude Founder and friend of Dr. Williams, Dr. Lary Robinson> March 28, 2018 marked the end of an era at Moffitt Cancer Center with the passing of thoracic oncologist, Dr. Charles Williams. On his drive to his busy clinic that morning to see lung cancer patients, a speeder ran a…

Continue Reading

Our Twitter feed

The decline in the death rate is attributed in large part to fewer people smoking. Smoking causes about 20 percent of all cancers and 30 percent of all cancer deaths in the United States. https://t.co/S83LXDYMqs
If you're an online shopper, Prime Day 2022 is a two-day sell-a-bration of great deals happening July 12-13. If you're a prime member, remember when you shop through the https://t.co/f5TxjaK5M8 portal, you can designate Prelude to a Cure to receive a percentage of your purchases. https://t.co/K3NiXIYBqb PreludetoaCure1 photo
Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. Experts say the results may be transformative for patients. https://t.co/ED6y3t16ZV
"The vaping issue took on new urgency in 2018 when Juul’s high-nicotine, fruity-flavored cartridges quickly became a nationwide craze among middle and high school students." https://t.co/KEhb18Gk6R
A recent study by Wiley published online in CANCER, a peer-reviewed journal of the American Cancer Society, found that education and income in the area were related to the stage of patients’ lung cancer at the time of diagnosis. Read more at https://t.co/jmWLXNOGgG. https://t.co/FlEjkEKJXh PreludetoaCure1 photo
Lung cancer kills more American women than ovarian, breast and uterine cancer combined each year. Like Prelude to a Cure, the UChicago Medicine Lung Cancer Team is looking to raise awareness and encourage women to be screened for the illness. https://t.co/P3sfR2qxM9